Device Center Promises Stronger Focus On Women’s Health
Executive Summary
Women would be better represented in clinical research and device development under a new strategic plan from the US FDA.
You may also be interested in...
Refined FDA Analysis Report Finds 2 Fewer Deaths Linked To Essure
In a 15 September update of adverse events from Bayer’s now-defunct Essure birth control device, the US agency tallies patients’ unwanted pregnancies and describes serious injuries.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.